BMPR2 and pulmonary arterial hypertension: Trying to understand the low penetrance of BMPR2 and the yet unidentified genetic causes of the remaining 20% of the hereditary form of PAH, new research strategies have shifted towards using next-generation sequencing (NGS) in the search for additional mutations or compound interactions of known genes [17].